NM_000533.5:c.2T>C
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000533.5(PLP1):c.2T>C(p.Met1?) variant causes a start lost, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000533.5 start_lost, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 2 Pathogenic:1
This sequence change affects the initiator methionine of the PLP1 mRNA. This variant has been reported in the literature and is not present in population databases. This variant was reported in 2 individuals affected with Pelizaeus-Merzbacher disease. Currently there is insufficient evidence to conclude whether this variant segregates with disease or not (PMID: 10417279, 18470932). Different mutations in the initiator codon (p.Met1Val, p.Met1Ile, p.Met1Arg) have been reported in patients affected with Pelizaeus-Merzbacher disease (PMID: 12910435, 8786077, 22343157), indicating that this residue may be critical for protein function. An experimental study using RT-PCR from one patient's fibroblasts has shown that this missense change causes loss of transcript (PMID: 18470932). For these reasons, this variant has been classified as Pathogenic. -
Inborn genetic diseases Pathogenic:1
The c.2T>C (p.M1?) alteration is located in coding exon 1 of the PLP1 gene and results from a T to C substitution at nucleotide position 2. This alters the methionine residue at the initiation codon (ATG). Sequence variations that modify the initiation codon are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame. Based on data from the Genome Aggregation Database (gnomAD), the PLP1 c.2T>C alteration was not observed, with coverage at this position. This alteration was previously reported in a patient with sporadic Pelizaeus-Merzbacher Disease (Mimault, 1999). Other alterations affecting the initiation codon, c.1A>G, c.2T>G, and c.3G>A, were described in families affected with hereditary spastic paraplegia or PMD (Hand, 2012; Hebbar, 2018; Plecko, 2003). The p.M1 amino acid is conserved in available vertebrate species. Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at